LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1

por Huang, Jiayuan, Pan, Banzhou, Xia, Guohao, Zhu, Jingni, Li, Chenchen, Feng, Jifeng
Publicado 2020

Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysis

por Hu, Ran, Zhao, Zhiting, Shi, Yue, Shi, Meiqi, Xia, Guohao, Yu, Shaorong, Feng, Jifeng
Publicado 2021

Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case report

por Xia, Guohao, Huang, Jiayuan, Ni, Jie, Song, Meng, Zhang, Junling, Hofman, Paul, Christopoulos, Petros, Grenda, Anna, Huang, Mengli
Publicado 2023

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

por Zhao, Zhiting, Zhao, Luqing, Xia, Guohao, Lu, Jianwei, Shen, Bo, Zhou, Guoren, Wu, Fenglei, Hu, Xiao, Feng, Jifeng, Yu, Shaorong
Publicado 2023